Peder Svensson
0000-0002-4233-5816
Publication & Citation Trends
Publications
0 total
Rational antibody design for undruggable targets using kinetically controlled biomolecular probes OA
Cited by 10
Semantic Scholar
(3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent OA
Cited by 5
Semantic Scholar
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease OA
Cited by 19
Semantic Scholar
Hip to be square: oxetanes as design elements to alter metabolic pathways.
Cited by 20
Semantic Scholar
Oxetane Substrates of Human Microsomal Epoxide Hydrolase OA
Cited by 13
Semantic Scholar
Active Compounds : A Structured Tool for CNS Drug Discovery
Cited by 12
Semantic Scholar
Running title : Oxetane Substrates of Human Microsomal Epoxide Hydrolase
Cited by 0
Semantic Scholar
State of affairs: Design and structure-activity relationships of reversible P2Y12 receptor antagonists.
Cited by 15
Semantic Scholar
Research Topics
Receptor Mechanisms and Signaling
(12)
Neurotransmitter Receptor Influence on Behavior
(7)
Computational Drug Discovery Methods
(5)
Advanced Chemical Physics Studies
(4)
Neuroscience and Neuropharmacology Research
(3)
Affiliations
AstraZeneca (United Kingdom)
SKF (Sweden)
University of Bradford
University of Cagliari
Manchester Academic Health Science Centre